Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.

What was recalled

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories

Recalling firm: Amerisource Health Services LLC
NDC code: 68001-501-00
Origin: OH, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0269-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metoprolol recalls

See all

Class II · Moderate risk Ongoing Apr 27, 2026